BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 219 filers reported holding BLUEBIRD BIO INC in Q1 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $7,000 | -12.5% | 50 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $8,000 | -11.1% | 50 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $9,000 | 0.0% | 50 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $9,000 | +28.6% | 50 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $7,000 | -36.4% | 50 | -50.0% | 0.00% | -40.0% |
| Q2 2017 | $11,000 | -15.4% | 100 | -28.6% | 0.01% | -28.6% |
| Q1 2017 | $13,000 | +44.4% | 140 | 0.0% | 0.01% | +40.0% |
| Q4 2016 | $9,000 | – | 140 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,964,000 | $59,215,000 | 1.36% |
| Birchview Capital, LP | 75,500 | $2,276,000 | 1.35% |
| Camber Capital Management LP | 1,000,000 | $30,150,000 | 1.04% |
| Sessa Capital IM, L.P. | 875,000 | $26,381,000 | 1.02% |
| Bain Capital Life Sciences Investors, LLC | 538,179 | $16,226,000 | 0.92% |
| Tarsadia Capital, LLC | 100,000 | $3,015,000 | 0.81% |
| Bullseye Asset Management LLC | 67,872 | $2,046,000 | 0.76% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,304,246 | $39,323,000 | 0.58% |
| MANGROVE PARTNERS IM, LLC | 175,178 | $5,282,000 | 0.53% |
| Parametrica Management Ltd | 37,712 | $1,080,000 | 0.52% |